Thanks to effective antiretroviral therapy, many people living with HIV can achieve a normal or near-normal life expectancy. As new data and new antiretroviral drugs and formulations become available, ...

The Institute for Clinical and Economic Review flagged five drugs whose prices were raised in 2023 with no evidence to ...

That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...

While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...

The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.

Researchers are attempting to improve the uptake of lifesaving HIV medication for infants and children by masking the ...

Request To Download Free Sample of This Strategic Report @- In the medication class, the multi-class combination drugs segment holds the largest market share as it involves the most advanced ...